Antimüllerian hormone: A marker for prediction of ovarian function and polycystic ovary syndrome

Journal of the Chinese Medical Association

Volumn 75, Issue 3, 2012, Pages 93-94

  Seow, Kok Min ^a,b   Wang, Peng Hui ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EDITORIAL; ENDOCRINOLOGY; GYNECOLOGY; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MENOPAUSE; MENSTRUAL CYCLE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PREDICTIVE VALUE; REPRODUCTION; SENSITIVITY AND SPECIFICITY;

ANTI-MULLERIAN HORMONE; FEMALE; HUMANS; OVARY; POLYCYSTIC OVARY SYNDROME;

EID: 84862793377     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.12.014     Document Type: Editorial

References (11)

1. Cate R.L., Mattaliano R.J., Hession C., Tizard R., Farber N.M., Cheung A., et al. Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell 1986, 45:685-698.
2. Tran N.D., Cedars M.I., Rosen M.P. The role of anti-Mullerian hormone (AMH) in assessing ovarian reserve. J Clin Endocrinol Metab 2011, 96:3609-3614.
3. Loh J., Maheshwari A. Anti-Mullerian hormone - is it a crystal ball for predicting ovarian ageing?. Hum Reprod 2011, 26:2925-2932.
4. Chao K.C., Ho C.H., Shyong W.Y., Huang C.Y., Tsai S.C., Cheng H.Y., et al. Anti-mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women. J Chin Med Assoc 2012, 75:70-74.
5. Shaw C.M., Stanczyk F.Z., Egleston B.L., Kahle L.L., Spittle C.S., Godwin A.K., et al. Serum antimüllerian hormone in healthy premenopausal women. Fertil Steril 2011, 95:2718-2721.
6. Seow K.M., Hwang J.L., Wang P.H., Ho L.T., Juan C.C. Peripheral blood mononuclear cell visfatin mRNA expression is not correlated to omental adipose visfatin mRNA in women with polycystic ovary syndrome. Hum Reprod 2011, 26:2869-2873.
7. Seow K.M., Lin Y.H., Hwang J.L., Wang P.H., Ho L.T., Lin Y.H., et al. Expression levels of haem oxygenase-1 in the omental adipose tissue and peripheral blood mononuclear cells of women with polycystic ovary syndrome. Hum Reprod 2011, 26:431-437.
8. Cook C.L., Siow Y., Brenner A.G., Fallat M.E. Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 2002, 77:141-146.
9. Pigny P., Jonard S., Robert Y., Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 2006, 91:941-945.
10. La Marca A., Orvieto R., Giulini S., Jasonni V.M., Volpe A., De Leo V. Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril 2004, 82:970-972.
11. Piltonen T., Morin-Papunen L., Koivunen R., Perheentupa A., Ruokonen A., Tapanainen J.S. Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005, 20:1820-1826.